CDPH Health Alert: Concerns re: the Use of Bamlanivimab Monotherapy in the Setting of SARS-CoV-2 Variants March 22, 2021 Bamlanivimab is an investigational monoclonal antibody product that received emergency use authorization (EUA) from the U.S. Food and Drug ... Read More